A minimal common outcome measure set for COVID-19 clinical research
The Lancet Infectious Diseases2020Vol. 20(8), pp. e192–e197
Citations Over TimeTop 1% of 2020 papers
John C. Marshall, Srinivas Murthy, Janet Dı́az, Neeta Adhikari, Derek Angus, Yaseen M. Arabi, J. Kenneth Baillie, Michael Bauer, Scott Berry, Bronagh Blackwood, Marc J. M. Bonten, Fernando A. Bozza, Frank M. Brunkhorst, Allen Cheng, Mike Clarke, Vu Quoc Dat, Menno D. de Jong, Justin T. Denholm, Lennie Derde, Jake Dunning, Xiaobin Feng, Tom Fletcher, Nadine E. Foster, Rob Fowler, Nina Gobat, Charles D. Gomersall, Anthony Gordon, Thomas Glueck, Michael O. Harhay, Carol Hodgson, Peter Horby, Yae‐Jean Kim, Richard Kojan, Bharath Kumar, John G. Laffey, Denis Malvey, Ignacio Martín‐Loeches, Colin McArthur, Daniel F. McAuley, Stephen McBride, Shay McGuinness, Laura Merson, Susan C. Morpeth, Dale M. Needham, Mihai G. Netea, Myoung‐don Oh, Sabai Phyu, Simone Piva, Ruijin Qiu, Halima Salisu-Kabara, Lei Shi, Naoki Shimizu, Jorge Sinclair, Steven Y. C. Tong, Alexis F. Turgeon, Tim Uyeki, Frank L. van de Veerdonk, Steve Webb, Paula Williamson, Timo Wolf, Junhua Zhang
Related Papers
- → Chilblain‐like lesions after BNT162b2 mRNA COVID‐19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS‐CoV‐2(2021)26 cited
- → And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan(2020)27 cited
- → ОПЫТ ИССЛЕДОВАНИЯ СЕРОПРЕВАЛЕНТНОСТИ К ВИРУСУ SARS-CoV-2 НАСЕЛЕНИЯ ИРКУТСКОЙ ОБЛАСТИ В ПЕРИОД ВСПЫШКИ COVID-19(2020)2 cited
- → Особенности сахароснижающей фармакотерапии у пациентов с SARS-CoV-2 (COVID-19)(2021)